Health Benefits of Endurance Training: Implications of the Brain-Derived Neurotrophic Factor—A Systematic Review by Włodzimierz Mrówczyński

“…Thus, this report presents the influence of endurance exercises on the (1) transformation of motoneuron properties, which are a final element of the motor pathways, (2) reduction of motor deficits evoked by Parkinson disease, and (3) prevention of the metabolic syndrome (MetS). This review suggests that the increase of posttraining levels of BDNF and its TrkB receptors causes simultaneous changes in the activity of the spinal cord, the substantia nigra, and the hypothalamic nuclei neurons, which are responsible for the alteration of the functional properties of motoneurons innervating the skeletal muscles, for the enhancement of dopamine release in the brain, and for the modulation of hormone levels involved in regulating the metabolic processes, responsively. …”
Get full text

Androgens and Adipose Tissue in Males: A Complex and Reciprocal Interplay by Caterina Mammi, Matilde Calanchini, Antonella Antelmi, Francesca Cinti, Giuseppe M. C. Rosano, Andrea Lenzi, Massimiliano Caprio, Andrea Fabbri

“…Clinical evidence shows that in males obesity is frequently associated with hypogonadism and vice versa; also, low testosterone levels have been considered a “hallmark” of metabolic syndrome in men. These observations indicate that there is a strict connection between anatomically and functionally distinct cell types such as white adipocytes and Leydig cells, that synthesize testosterone. …”
Get full text

Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease by Paweł Rajewski, Jakub Cieściński, Piotr Rajewski, Szymon Suwała, Alicja Rajewska, Maciej Potasz

“…The main cause of MASLD is an inappropriate lifestyle—inadequate nutrition and insufficient physical activity, which lead to various components of metabolic syndrome. Lifestyle changes—appropriate diet, weight reduction, and systematic physical activity—are also the basis for the prevention and treatment of MASLD. …”
Get full text

Anthropometric Indicators to Determine the Obesity and its Relations with the Cardiometabolic Risk by Raúl Cedeño Morales, Maricel Castellanos González, Mikhail Benet Rodríguez, Luis Mass Sosa, Carlos Mora Hernández, Jorge Carlos Parada Arias

“…There is a narrow correlation among individuals with altered abdominal waist and the criteria established for the diagnosis of metabolic syndrome. <br /><strong>Conclusions:</strong> the perimeter of waist constitutes a parameter of essential measure in the obese patient's evaluation, independently of the IMC, since it has been demonstrated a positive association between abdominal obesity and cardiometabolic risk.…”
Get full text

The Role of the Self-Differentiation and Mindfulness in Predicting Disturbed Eating Behaviors in Adolescent’s Diabetic by Khadijeh Khoddari, Sana Nourimoghadam

“…Introduction: Diabetes is a chronic metabolic syndrome and the most prevalent endocrine disorder. …”
Get full text

Obesity Increases Prevalence of Colonic Adenomas at Screening Colonoscopy: A Canadian Community-Based Study by Theodore F. Shapero, Grant I. Chen, Tim Devlin, Alison Gibbs, Iain C. Murray, Stanley Tran, Corey Weigensberg

“…We examined the influence of obesity and metabolic syndrome (MetS) on prevalence of neoplasia at screening colonoscopy. …”
Get full text

Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects by Sándor Somodi, Ildikó Seres, Hajnalka Lőrincz, Mariann Harangi, Péter Fülöp, György Paragh

“…The elevated level of plasminogen activator inhibitor-1 (PAI-1) in obese subjects with metabolic syndrome and in patients with type 2 diabetes is well established. …”
Get full text

Awareness and attitudes of pregnant women concerning genetic disorders and pregnancy termination in northeastern Iran by Nafiseh Todarbary, Abouzar Irandegani, Mojtaba Meshkat, Aida Gholoobi, Tayebeh Hamzehloei

Get full text

Long-Term Metabolic Outcomes after Gestational Diabetes Mellitus (GDM): Results from the Odense GDM Follow-Up Study (OGFUS) by Kristine Hovde Jacobsen, Jori Aalders, Katrine Sølling, Marianne Skovsager Andersen, Lena Sønder Snogdal, Maria Hornstrup Christensen, Christina Anne Vinter, Kurt Højlund, Dorte Møller Jensen

“…For women with pGDM, the prevalence of prediabetes (38%) and the metabolic syndrome (MetS) (59%) were approximately 3-fold higher than in non-GDM women (p’s<0.001). …”
Get full text

High-fat diet triggers transcriptomic changes in the olfactory bulb by Young-Kook Kim, Danbi Jo, Seoyoon Choi, Juhyun Song

“…Thus, our findings suggest potential therapeutic targets for treating olfactory dysfunction and related neural disorders in individuals with metabolic syndrome.…”
Get full text

The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes by Basilio Pintaudi, Giacoma Di Vieste, Matteo Bonomo

“…Inositol has been used as a supplement in treating several pathologies such as PCOS, metabolic syndrome, and gestational diabetes. Both myo-inositol and its isomer d-chiro-inositol showed insulin mimetic effects in conditions of insulin resistance. …”
Get full text

Atherosclerosis and Rheumatoid Arthritis: More Than a Simple Association by Lorenzo Cavagna, Nicola Boffini, Giovanni Cagnotto, Flora Inverardi, Vittorio Grosso, Roberto Caporali

“…Moreover, atherosclerosis may be directly mediated also by underlying autoimmune processes, and indirectly by the occurrence of metabolic syndrome and impaired physical activity. Finally, the effects of RA therapies on cardiovascular system in general and on atherosclerosis in particular are really wide and different. …”
Get full text

OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease by Elena Paschetta, Paola Belci, Anna Alisi, Daniela Liccardo, Renato Cutrera, Giovanni Musso, Valerio Nobili

“…Obstructive sleep apnoea syndrome (OSAS) is a common sleep disorder, affecting over 4% of the general population, and is associated with metabolic syndrome and cardiovascular disease, independent of obesity and traditional risk factors. …”
Get full text

The Effect of Hypertension Duration and the Age of Onset on CV Risk Factors Expression in Perimenopausal Women by Ljiljana Trtica Majnarić, Ivo Martinović, Šefket Šabanović, Stjepan Rudan, František Babič, Thomas Wittlinger

“…The impact of hypertension duration and the time of onset on the expression of metabolic syndrome (MS) and other CV risk factors, in perimenopausal women, have not been studied so far. …”
Get full text

Mechanistic relationship between obesity-induced inflammation triggering endothelial dysfunction and the initiation of atherosclerosis development by Richard L. Jayaraj, Elhadi H Aburawi

“…Obesity is a multifactorial, chronic inflammatory illness that affects individuals of all ages; it is linked to several cardiovascular and metabolic syndromes. Excessive accumulation of fat that impairs metabolic processes is a key feature of obesity. …”
Get full text

Two Sudden and Unexpected Deaths of Patients with Schizophrenia Associated with Intramuscular Injections of Antipsychotics and Practice Guidelines to Limit the Use of High Doses of... by Nasratullah Wahidi, Katie M. Johnson, Allen Brenzel, Jose de Leon

“…The second case involves a 42-year-old African-American female with metabolic syndrome. Her probable cause of death was the last ziprasidone IM injection of 20 mg in addition to (1) three extra haloperidol doses (2 hours before the ziprasidone injection, 5 mg oral haloperidol; approximately 21 hours earlier, 5 mg oral haloperidol; and 2 days prior, one 10 mg IM haloperidol injection), (2) 10 mg/day of scheduled oral haloperidol for 6 days before death, and (3) a long-acting paliperidone injection of 156 mg 18 days before death. …”
Get full text

Resistin Activates p65 Pathway and Reduces Glycogen Content through Keratin 8 by Fengyun Wen, Qiao Xia, Hui Zhang, Haipeng Shia, Amin Rajesh, Yanling Wu, Yi Yang, Zaiqing Yang

“…Resistin is associated with metabolic syndrome and inflammatory conditions. Many studies have suggested that resistin inhibits the accumulation of glycogen; however, the exact mechanisms of resistin-induced decrease in glycogen content remain unclear. …”
Get full text

Adrenal Insufficiency in Coronavirus Disease 2019 (COVID-19)-Infected Patients without Preexisting Adrenal Diseases: A Systematic Literature Review by Mehrbod Vakhshoori, Maryam Heidarpour, Niloofar Bondariyan, Niyousha Sadeghpour, Zohreh Mousavi

Get full text

All-Cause Mortality Risk of Metabolically Healthy Obese Individuals in NHANES III by C. M. Durward, T. J. Hartman, S. M. Nickols-Richardson

“…Metabolic health was defined as: (1) homeostasis model assessment-insulin resistance (HOMA-IR) <2.5; (2) ≤2 Adult Treatment Panel (ATP) III metabolic syndrome criteria; (3) combined definition using ≤1 of the following: HOMA-IR ≥1.95 (or diabetes medications), triglycerides ≥1.7 mmol/L, HDL-C <1.04 mmol/L (males) or <1.30 mmol/L (females), LDL-C ≥2.6 mmol/L, and total cholesterol ≥5.2 mmol/L (or cholesterol-lowering medications). …”
Get full text

Capillary microfluidics for diagnostic applications: fundamentals, mechanisms, and capillarics by Elham Khanjani, Andrea Fergola, Joan Antoni López Martínez, Simin Nazarnezhad, Simin Nazarnezhad, Jasmina Casals Terre, Simone Luigi Marasso, Simone Luigi Marasso, Behrouz Aghajanloo

Get full text